Controversies of renin–angiotensin system inhibition during the COVID-19 pandemicAndrew M. South, Matthew A. Sparks, Swapnil Hiremath et al.|Nature Reviews Nephrology|2020Cited by 292
Pulmonary Hypertension Subtypes and Mortality in CKDDaniel Edmonston, Myles Wolf, Alexander Grabner et al.|American Journal of Kidney Diseases|2019Cited by 67
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin IIKeisuke Okuno, Satoru Eguchi, Keiichi Torimoto et al.|Hypertension|2023Cited by 34
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin SystemDaniel Edmonston, Jordana B. Cohen, Andrew M. South et al.|Advances in Chronic Kidney Disease|2020Cited by 18
Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in MiceSatoru Eguchi, Jia L. Zhuo, Hong Lü et al.|Canadian Journal of Cardiology|2023Cited by 10